Dabomb Protein Cash Flow Conversion Efficiency
Dabomb Protein cash flow conversion efficiency. Based on the latest financial reports, Dabomb Protein (6578) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-354.00K ≈ $-11.15K USD) by net assets (NT$989.28 Million ≈ $31.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Dabomb Protein (2015–2025)
Cash flow conversion efficiency of Dabomb Protein from 2015 to 2025. This chart illustrates how Dabomb Protein's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dabomb Protein (6578) stock price for real-time trading data and today's change.
Dabomb Protein Cash Flow Conversion Ratio Explained
Dabomb Protein cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Dabomb Protein Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dabomb Protein ranked by their cash flow conversion efficiency. Also see Dabomb Protein market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Koan Hao Technology Co Ltd
TWO:8354
|
0.003x |
|
Retail Food Group Ltd
AU:RFG
|
0.000x |
|
KB No.2 Special Purpose Acq
KQ:192250
|
-0.002x |
|
Career Point Limited
NSE:CAREERP
|
0.004x |
|
ESTsoft Corp
KQ:047560
|
-0.074x |
|
Donaco International Ltd
AU:DNA
|
0.032x |
|
eSang Networks Co.Ltd
KQ:080010
|
0.049x |
|
IG Group Holdings PLC
LSE:IGG
|
0.144x |
Annual Cash Flow Conversion Efficiency for Dabomb Protein (2015–2025)
The table below shows the annual cash flow conversion efficiency of Dabomb Protein from 2015 to 2025. Review 6578 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$989.28 Million ≈ $31.17 Million |
NT$16.65 Million ≈ $524.44K |
0.017x | -61.46% |
| 2024-12-31 | NT$1.09 Billion ≈ $34.32 Million |
NT$47.55 Million ≈ $1.50 Million |
0.044x | +542.86% |
| 2023-12-31 | NT$958.06 Million ≈ $30.18 Million |
NT$6.51 Million ≈ $204.97K |
0.007x | -74.94% |
| 2022-12-31 | NT$727.20 Million ≈ $22.91 Million |
NT$19.71 Million ≈ $620.85K |
0.027x | +141.29% |
| 2021-12-31 | NT$674.24 Million ≈ $21.24 Million |
NT$-44.25 Million ≈ $-1.39 Million |
-0.066x | -442.83% |
| 2020-12-31 | NT$700.51 Million ≈ $22.07 Million |
NT$13.41 Million ≈ $422.52K |
0.019x | -59.80% |
| 2019-12-31 | NT$698.39 Million ≈ $22.00 Million |
NT$33.26 Million ≈ $1.05 Million |
0.048x | +53.30% |
| 2018-12-31 | NT$710.52 Million ≈ $22.39 Million |
NT$22.07 Million ≈ $695.42K |
0.031x | -55.90% |
| 2017-12-31 | NT$622.77 Million ≈ $19.62 Million |
NT$43.87 Million ≈ $1.38 Million |
0.070x | -26.73% |
| 2016-12-31 | NT$619.77 Million ≈ $19.53 Million |
NT$59.58 Million ≈ $1.88 Million |
0.096x | -59.24% |
| 2015-12-31 | NT$592.64 Million ≈ $18.67 Million |
NT$139.78 Million ≈ $4.40 Million |
0.236x | -- |
About Dabomb Protein
DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more